- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Dalradian Intercepts 1.83 Metres of 37.41 g/t of Gold at Tyrone Project
Dalradian Resources Inc. (TSE:DNA) extends a high grade zone in the T17 vein 85 metres vertically below the exploration adit at its Curraghinalt gold deposit in Northern Ireland.
Dalradian Resources Inc. (TSX:DNA) extends a high grade zone in the T17 vein 85 metres vertically below the exploration adit at its Curraghinalt gold deposit in Northern Ireland.
The press release is quoted as saying:
“These results demonstrate the presence of more high grade mineralization associated with the T17 vein that we intend to follow to depth,” said Patrick F. N. Anderson, Dalradian’s chairman and chief executive officer. “Moreover, results from the Bend and the Crow veins illustrate the potential to find new mineralized veins not included in the existing resource estimate.”
Click here to access the entire press release
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.